Zu "391210-10-9" wurden 4 Artikel gefunden!

Für die Filterung wurden keine Ergebnisse gefunden!
PD 0325901
PD 0325901

Artikelnummer: Cay13034-25

The dual specific threonine/tyrosine kinase MEK is a key component of the RAS/RAF/MEK/ERK signaling pathway that is frequently activated in human tumors. PD 0325901 is a potent MEK inhibitor that suppresses phosphorylation of ERK in mouse colon 26 tumors with an IC50 value of 0.33 nM. Suppression of ERK activation...
Schlagworte: N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-benzamide
Anwendung: MEK inhibitor
CAS 391210-10-9
MW: 482.2 D
ab 73,00 €
Bewerten
Mirdametinib
Mirdametinib

Artikelnummer: TGM-T6189-50mg

Description: Mirdametinib (PD325901) is an MEK inhibitor (IC50=0.33 nM) with selective, non-ATP-competitive, and oral activity. Mirdametinib exhibits antitumor activity by inhibiting p-ERK1/2 expression and inducing apoptosis. Target: Autophagy, MEK, Apoptosis. Smiles:...
Schlagworte: PD0325901, PD325901
Anwendung: Targets mitogen-activated protein kinase kinase 1 [EC:2.7.12.2] (MAP2K1, MEK1)
CAS 391210-10-9
MW: 482.19 D
ab 45,00 €
Bewerten
PD325901
PD325901

Artikelnummer: LKT-P1202.100

A potent inhibitor of MEK, a key component of the Mitogen activated protein kinase (MAPK) cascade. It has been found to inhibit tumor cell growth, has antiangiogenic and antiproliferative activities.
Anwendung: MEK inhibitor
CAS 391210-10-9
MW: 482,19 D
ab 201,00 €
Bewerten
PD 0325901
PD 0325901

Artikelnummer: AG-CR1-3711-M001

White to off-white solid. Soluble in DMSO (20mg/ml) or ethanol (15mg/ml). Chemical. CAS: 391210-10-9. Formula: C16H14F3IN2O4. MW: 482.2. PD 0325901 is a potent and selective non-ATP competitive orally active MEK1 and MEK2 inhibitor. In comparison to the CI-1040 MEK inhibitor that PD 0325901 has a greater potency of...
Schlagworte: Mirdametinib, N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-benzamide
CAS 391210-10-9
MW: 482,2 D
ab 28,00 €
Bewerten